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Abstract
Experiments were performed to test sequence and structural specific interactions of
proteins with a conserved RNA modification enzyme, which is known as Ime4 in yeast and
Mettl3 in mammals. Ime4 methylates N6-adenosine bases on mRNA molecules. The goal of this
project is to gain direct insights into how novel proteins interact with Ime4 to form the
methyltranferase (MTase) complex and to identify proteins that are essential for Ime4 activity. It
has been recognized that there are two proteins that interact within the Ime4 complex, which are
known as Mum2 (a cytoplasmic protein essential for meiotic DNA replication within yeast) and
Slz1 (a transcription factor). We hypothesize that the N-terminal domain of Ime4 is the location
of binding of the aforementioned proteins in this complex. Similarly, we tested whether the
human ortholog of Ime4 (Mettl3) forms an analogous complex that includes an ortholog of
Mum2, known as WTAP, and its binding partner WT1. The major approaches include in vivo
genetic assays in yeast to test protein-protein interactions and the use of recombinant DNA
technology to construct fusion genes/deletions. The results demonstrate that Mum2 interacts with
a specific, non-conserved region in the Ime4 N-terminal domain. Furthermore, we discovered a
new binding partner, Ygl036w, which also interacts with Ime4. Currently, several experiments
are being carried out with the Mettl3 complex and its hypothesized protein binding partners to
assess the interactions of this complex.

Key Terms: m6A, IME4, METTL3, RNA Methylation, MUM2, WT1, WTAP,
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Introduction
Importance of protein-protein interactions
Protein-protein interactions are essential for the regulation of many processes within
cells. An understanding of how proteins function as complexes is crucial to understanding how
organisms live. Proteins regulate all biological systems, and although some proteins perform
independent functions, most interact with other proteins to perform necessary biological
activities. Understanding the function of single proteins is essential to understanding the function
of a protein complex. But because most proteins interact with other proteins to carry out their
functions, it is important to study the interacting protein in its entirety to fully appreciate a
protein’s exact function within a cell.
Protein-protein interactions are necessary for cell proliferation, nutrient uptake,
morphology, motility, gene expression, intercellular communication, and control of cell
homeostasis, among others. Many aspects of protein-protein interactions are necessary to
understand how a protein carries out its functions. The amino acid sequence and its structure may
be used to ascertain motifs that identify the likely function of a protein. Conserved sequences are
especially important in revealing orthologous proteins from different organisms. Also, conserved
sequences found in different organisms may help identify residues that are crucial to the
regulation of protein function. Expression profiles can explain the specificity of cell type and
how expression is modulated within cells. Also, the function of proteins may be examined by
how they are post-translationally modified or how they modify other proteins. Post-translational
modifications may regulate the activity of proteins, where they localize, and how they are
activated (Protein-protein Interactions: a Molecular Cloning Manual 2005). Moreover, the
localization of proteins may suggest the function of a protein or provide an understanding of the
1

proteins that a specific protein may interact with to help it carry out its function. Most
importantly, the function of proteins can be elucidated by understanding their interactions with
other proteins.
Protein-protein interactions appear in two forms, transient and stable. Stable interactions
are characteristic of proteins that are involved in multi-subunit complexes, containing different
or identical subunits. Proteins involved in stable interactions may help stabilize a complex of
proteins. There may be many proteins interacting in a complex that centers around one protein.
In a sense, different protein-protein interactions may help assemble a multi-subunit complex to
strengthen the functions of specific proteins. Or proteins may interact with one another to
regulate the catalytic activity of specific proteins.
In contrast, transient protein interactions are believed to govern most cellular processes
(Protein-protein Interactions: a Molecular Cloning Manual 2005). A transient interaction is an
interaction that is temporary. Transient interactions are also known as unstable interactions,
because unlike stable interactions, transient interactions occur rapidly and usually include an
association of two proteins. Transient interactions regulate cellular processes including transport,
folding, cell cycling, and protein modifications. Protein-protein interactions are essential to cell
viability. In general, cells perform many functions that are necessary for the survival of the entire
organism as a whole. Without protein-protein interactions, cells will not be able to perform the
functions necessary for maintenance and regulation of an organism. Ultimately, a cell depends
on both stable and transient interactions for the upkeep of an entire organism.
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N6-methyl-adenosine (m6A)
As explained, protein-protein interactions are important for the regulation of many
cellular processes. One such process found in all organisms is mRNA methylation, an important
posttranscriptional modification of adenosine residues known as N6-methyl-adenosine (m6A). As
the most common modification of RNA molecules in eukaryotes, m6A may serve as a
significant, novel epigenetic marker in all organisms (Niu et al. 2013). The m6A modification is
catalyzed by specific proteins known as Ime4 in Saccharomyces cerevisiae, Mettl3 in Homo
sapiens, Dm Ime4 in Drosophila melanogaster, and MTA in Arabidopsis thaliana. These four
proteins have been extensively researched in terms of how this modification affects transcript,
protein, developmental, and metabolic functions (Jia, Fu, and He 2013). The m6A modification
seems to be evolutionarily conserved, and may function to regulate gametogenesis in eukaryotes
(Clancy et al. 2002; Hongay and Orr-Weaver 2011). The Ime4 protein in yeast remains to be the
most extensively studied and multiple Ime4 interacting proteins have been discovered.
Saccharomyces cerevisiae interacts with its environment and receives a variety of
nutritional and genetic signals to activate cellular developmental pathways including sporulation
and mating. Through many very involved and intricate experiments, it was found that Ime4
activated a variety of sporulation specific genes that ultimately lead to the formation of haploid
spores through a specific modification of mRNA molecules (Shah and Clancy 1992). Once Ime4
becomes active, it initiates a mechanism by which the catalytic motif IV catalyzes methylation of
N6-adenosine residues (m6A) in polyadenylated mRNA within yeast cells that are sporulating
(Clancy et al. 2002). Modified targets may include mRNAs of IME1, IME2, NDT80, IME4
itself, and other sporulation specific transcripts at particular adenosine residues (Bodi et al.
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2010). The m6A modification may cause alterations of these mRNAs, in which lead to changes
in stability, splicing, efficient translation, or compartmentalization (Clancy et al. 2002).
In accord, Ime4 may be viewed as a meditator for the activation of these genes through
this mechanism of methylating adenosine residues. Though the function of m6A is still
unidentified, it may cause the aforementioned functions. Strong evidence, through methylation
inhibitor experiments, indicates that the m6A modification may play a role in transcript splicing,
stability, translation efficiency, or compartmentalization in mammalian cells. Unfortunately, the
pleiotropic effects of these experiments cannot verify that m6A causes these transcripts to alter
their biogenesis (Clancy et al. 2002). Through the discovery of proteins involved in the protein
complex of Ime4, it may become clearer as to what function m6A coordinates. Two proteins have
already been discovered to interact with Ime4, known as Mum2 and Slz1. This complex will be
explained later in the Introduction. The human ortholog of Ime4, MT-A70 (also referred to as
METTL3), may also have similar roles to Ime4, and also functions in a protein complex.
The m6A modification in humans is catalyzed by the MT-A70 subunit of a large protein
complex. The catalytic Mettl3 subunit is the only one that has been identified to date. This
catalysis by MT-A70 is believed to be involved in the regulation of many processes in humans
including embryonic development, gonad development, mRNA metabolism, and protein
expression (Niu et al. 2013). There is some evidence that the m6A modification may play a
regulatory role in the nuclear export machinery (Niu et al. 2013). This has been observed in
experiments

that

involve

HeLa

cells

treated

with

the

methylation

inhibitor

S-

Tubercidinylhomocysteine (STH), which showed that the retention time of mRNA in the nucleus
increased by 40% on average (Camper et al. 1984). Remarkably, high m6A activity was detected
in cells that underwent transformations as compared to non-transformed cells, indicating a
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relationship between cancer and m6A methylation (Tuck et al. 1996). Though m6A may be
involved in these processes, its exact function has yet to be elucidated. MT-A70 functions in a
virtually unknown protein complex that is presumed to involve many specific protein-protein
interactions. Discovering these protein-protein interactions in this unknown protein complex will
be important in elucidating the functions of the m6A modification.

Figure 1: N6-Methyl-adenosine (m6A)
Saccharomyces cerevisiae as a model organism
Saccharomyces cerevisiae is a model organism to study the cellular processes of
eukaryotes. Saccharomyces cerevisiae was the first eukaryote to have its genome sequenced
(Botstein, Chervitz, and Cherry 1997). This was an amazing feat because by having all of its
genome decoded, scientists have used yeast as a model to study human diseases such as cancer,
infections, and hereditary diseases. Determining the function of yeast proteins is critical to
understanding how human proteins function as well. The genome of yeast can be compared to
5

the human genome to assess the number of yeast genes that have noteworthy mammalian
homologs (Botstein, Chervitz, and Cherry 1997). Yeast cells also share a common fundamental
life cycle and cellular construction with more complex multicellular organisms, including
humans and plants (Mell and Burgess 2002). Yeast may contain 31% of protein encoding genes
that have robust mammalian homologous proteins (Botstein, Chervitz, and Cherry 1997). This
homology between yeast genes and human genes that encode functional proteins is the most
important reason Saccharomyces cerevisiae is used as the model organism for experimental
study. Yet, there are many more incentives to using yeast as a eukaryotic model organism for
experimental study.
Saccharomyces cerevisiae is in many ways analogous to the bacterial organisms scientist
use to conduct experiments. Bacteria such as E.coli, are easy to manipulate and many E.coli
strains are affordable for purchase. Yeast is similar to E.coli in this aspect, because yeast is also
simple to manipulate and strains are also affordable (Botstein, Chervitz, and Cherry 1997). Also,
segregation analysis and screening mutants are simpler to accomplish in yeast than in any other
multicellular organism (Mell and Burgess 2002). Performing experiments on yeast, such as
plasmid transformations, deletions, protein extractions and assays, mutagenesis of gene targets,
and knock out of targeted genes is important for investigators because these methods help to
identify functions of many different types of genes that may be similar to the human homolog of
these genes. Also, by performing the aforementioned experiments on yeast, scientists may be
able to solve complicated mechanisms of cellular pathways that are crucial for the understanding
of human disease processes. By using yeast as an experimental model, scientists are able to
induce mutations in yeast genes (e.g. metabolic genes) to demonstrate the importance of these
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genes in control of cellular pathways and regulations of cellular mechanisms (Mell and Burgess
2002).
Another incentive for using Saccharomyces cervisiae as an experimental model is that the
time required to perform experiments on yeast is relatively short in comparison to multicellular
organisms. A fundamental difference between using more complex eukaryotic models in
comparison to yeast is the amount of time required to grow these organisms. The generation time
is infinitesimal compared to the amount of time it would require to grow an organism such as a
mouse for experimentation. Saccharomyces cervisiae has a generation time of about 90 minutes,
and this is important when scientists need to observe rare events such as genetic mutations (Mell
and Burgess 2002). Because the generation time is so short, many millions of cells can be
cultured rapidly, and this increases the probability that a genetic mutation can be identified, with
its effects testable. For example, a mutagenesis experiment performed on yeast may require
three days, which is short in comparison to doing mutagenesis experiments on mice which may
require many months before a comprehensible result is obtained.
Mating of Saccharomyces cerevisiae and its role in its life cycle
Saccharomyces cerevisiae undergoes meiosis in nutrient-limiting environments.
Specifically, meiosis is induced by media that lacks nitrogen but contains an adequate respirable
carbon source, typically acetate. This is essential to the continued survival of yeast because they
can undergo major physical transformations that allow them to pass on and assort their genetic
information. Interestingly, yeasts are able to exist in both haploid and diploid forms. Glucose and
nitrogen deprivation causes biochemical changes to occur in diploid yeast cells, and these
alterations cause diploid yeast cells to change to their haploid forms through the process of
meiosis and spore formation (Wagstaff, Klapholz, and Esposito 1982). In their haploid forms,
7

yeast cells express alleles that differentiate the mating types of yeast cells. Haploid cells can
either be MATa or MATα, which are the alleles that phenotypically address the differences of
the two different sexes in haploid yeast cells. The MATa and MATα alleles of the mating type
locus regulate the expression of genes encoding pheromones known as ‘a pheromone’ and ‘α
pheromone’ and other genes involved in cell fusion. Pheromones induce intracellular changes
that cause the MATa and MATα cells to be attracted to one another, leading to the formation of
cell projections and consequentially to the formation of morphological structures called schmoos
(Bardwell 2004). Once the haploid cells fuse to one another, the nuclei also fuse causing the 16
chromosome haploid to become a 32 chromosome diploid known as the MATa/MATα cell
(Bardwell 2004). The resulting diploid does not mate, but can be propagated indefinitely
mitotically.
This mating process, in all, turns two haploid cells into a functional diploid cell which
may then undergo the process of meiosis to form four distinct haploid cells. Two of the four
haploid cells are MATa and the remaining two are MATα. This process is crucial to the survival
of yeast in harsh environments. Also, meiosis creates genetic variations through the process of
crossing over and exchange of genes from two distinct cells. This allows yeast to acquire gene
combinations that are necessary for survival in harsh habitats. The meiotic process that yeast
undergoes is very interesting. This same process occurs in higher eukaryotic organisms such as
mammals, but not in the same way. Meiosis only occurs in gamete cells in animals, but
identifying the genes that mediate meiosis in yeast may lead to a better understanding of how
meiosis operates in animals. Research has unequivocally identified the discovery of genes that
induce meiosis in Saccharomyces cerevisiae such as IME4, IME1, and IME2.
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IME4 and its role in sporulation in Saccharomyces cerevisiae
The expression of key activators is essential for ascosporogenesis and meiosis in yeast.
Meiosis and ascosporogenesis are complex processes involving the creation of genetic variation,
production of many new proteins, and turnover of foregoing cellular constituents (Clancy et al.
1983). “Early” genes such as IME1 and IME2 begin to be transcribed at about 1-2 hours in most
laboratory strains following the nutritional deprivation of Saccharomyce cerevisiae and may
decrease significantly thirteen hours following nutritional deprivation (Clancy et al. 1983). Some
sporulation-specific mRNAs are synthesized at about 7 hours, such as NDT80, which encodes a
transcription factor for genes involved in spore formation and exit from the pachytene stage of
meiosis (Jia, Fu, and He 2013). Three genes known as IME4, IME1, and IME2 are essential early
activators of meiosis in yeast. The activation of these genes is precisely regulated, and their
activation is essential for meiosis and spore formation. Though the mechanism of activation is
not fully understood, it is essential that these three genes, in lieu of the activation of other
sporulation-specific genes, be active for a certain time during meiosis.
Ime4 plays a very important role in the induction of meiosis in yeast that are nutritionally
deprived of nitrogen and that are placed on respirable carbon sources (Clancy et al. 2002). IME4
is located on the left arm of chromosome VII in between ADE5 and LYS5 (Shah and Clancy
1992). Its importance resides in the fact that it is finely regulated. IME4 is transcribed in low
quantities during the diploid lifecycle of MATa/MATα vegetative yeast cells (Shah and Clancy
1992). This is important because this transcript needs to be present in small quantities in order to
activate sporulation-specific transcripts when yeast cells are starved of their required nutrients
that maintain their viability. Ime4 is also known to methylate its own mRNA along with those of
other genes known as IME1 and IME2, among others (Bodi et al. 2010).
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Ime1 is a transcriptional activator of meiosis, and leads to the transcription of genes that
are required for sporulation (Kassir, Granot, and Simchen 1988). Ime1 induces a cascade of gene
expression that regulates meiosis and sporulation under starved conditions (Bodi et al. 2010).
Because of this cascade of gene activation, it is noted that more than five hundred new mRNA
transcripts exist during yeast meiosis (Chu et al. 1998). This is important because yeast cells
morph into entirely new cells and require different proteins to regulate this transformation. IME1
mRNA is not present in high amounts during the vegetative mitotic life cycle of yeast, and thus,
its regulation is dependent on other proteins (Shah and Clancy 1992). Its expression increases
rapidly during conditions where yeast cells are starved, and it leads to the activation of the two
genes encoding IME2 and NDT80 among many others that are needed for meiosis,
recombination, and chromosomal segregation.
Ime2 and Ndt80 play important roles in the regulation of meiosis. In order for sporulation
to occur correctly, Ime1 and Ime4 need to be inactivated at certain times as cells transition into
the meiotic process. In order for these proteins to be inactivated, they require the function of
Ime2 and Ndt80, respectively. Ime2 is a serine/threonine protein kinase that mediates the
stability of the Ime1 protein during meiosis, it is required for the degradation of Ime1, and also
for the activation of Ndt80 (Guttmann-Raviv, Martin, and Kassir 2002). Ime2 itself is very
unstable and is toxic in vegetative diploid yeast cells (Guttmann-Raviv, Martin, and Kassir
2002). By degrading Ime1, Ime2 down regulates the activity of Ime1. Ime2 phosphorylates the
C-terminal domain of Ime1, leading to its degradation by a 26S proteasome (Guttmann-Raviv,
Martin, and Kassir 2002). The interaction between Ime1 and Ime2 may be viewed as a negative
feedback loop. The activation of Ime1 causes activation of the Ime2 protein, and when the Ime2
protein is active at a certain point, it causes the degradation of Ime1. Ime2 is likely to
10

phosphorylate other protein targets as well (Guttmann-Raviv, Martin, and Kassir 2002). Ndt80,
on the other hand, is a meiosis-specific transcription factor that is essential for the progression of
yeast cells through the pachytene stage of meiosis and is responsible for activating the “middle”
group of sporulation specific genes (Xu et al. 1995). Ime4 may function to activate Ndt80, which
in turn down regulates IME4 during the middle phase of meiosis (Agarwala et al. 2012). This
may be achieved indirectly through the activation of Ime2, and/or directly by modification of
adenosine residues of the Ndt80 transcript (Agarwala et al. 2012). This modification is an
essential part of the Ime4 protein function. It functions to methylate the sporulation specific
transcripts that are part of the meiosis cycle in yeast.
The IME4 homolog, METTL3
The human ortholog of Ime4 is METTL3, also known as MT-A70. There is a 72%
sequence similarity between Ime4 and METTL3 proteins (Bokar et al. 1997). The METTL3
protein is found in human cells. This is significant because the homologs perform the same
function, which is to methylate mRNA transcripts. The entire protein complex consists of two
separable components known as MT-A and MT-B (Bokar et al. 1997). The total weight of these
components is 1075 kDa (200 kDa for MT-A and 875kDa for MT-B) as estimated by gel
filtration chromatography (Bokar et al. 1997). MT-A and MT-B contain multiple subunits, and
the subunit with catalytic activity is encoded by METTL3 (Bokar et al. 1997). METTL3 is the
gene that encodes the 70 kDa subunit of the human mRNA m6A MTase known as MT-A70,
which is located in the protein component MT-A (Bokar et al. 1997).
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Figure 2: Sequence Alignment of IME4
The function of the catalytic subunit is to methylate adenosine residues on mRNA
transcripts in humans, which is the exact function of Ime4 in yeast cells. This posttranscriptional
modification is also known as m6A in humans. The only difference is Ime4 methylates adenosine
residues on mRNA transcripts in yeast exhibiting sporulation. The function of m6A is still
unknown, wherever it is found (Bokar et al. 1997). Past experiments using HeLa cells have
shown that decreased levels of m6A coincide with a decreased level of newly transcribed mRNA
in the cytosol (Bokar et al. 1997). This finding suggests that this modification may play a role in
regulating the transport of mRNA from the nucleus to the cytoplasm. Also, m6A may play a role
in further posttranscriptional modifications. The evidence for this notion lies in inhibition
experiments on HeLa cells with decreased m6A found on newly transcribed mRNA transcripts. It
is shown that a decrease in the m6A modification results in aggregation of unspliced pre-mRNA
in the nucleus (Bokar et al. 1997). The modification by MT-A70 may also play a role in mRNA
metabolism.
12

The system by which MT-A70 expression is regulated has yet to be elucidated. It may be
regulated tissue specifically or developmentally, but research has yet to confirm this possibility
(Bokar et al. 1997). Ime4 is regulated in a timely fashion and is only active in yeast cells during
sporulation. Ime4 is also regulated by the decrease of antisense transcripts that is correlated with
an increase of sense transcripts (Agarwala et al. 2012). It has been confirmed that when a cell
undergoes a transformation of some sort, whether it is a viral infection or cellular transformation,
the content of adenosine residues that are methylated increases substantially (Bokar et al. 1997).
Transformations of adenovirus into rat embryonic cells resulted in a 7.5-fold increase in MT-A70
activity (Bokar et al. 1997). There may be a connection to the regulation of m6A modifications
in humans, and in some way, this modification may change the fate of specific mRNA
transcripts. More research should be done to understand this phenomenon.
Mum2 and Slz1 in complex with Ime4
Ime4 is known to interact with other proteins in order to carry out its function, which is to
methylate N6-adenosine residues on mRNA transcripts. This is a fairly new discovery, and these
protein-protein interactions complement one another. This protein complex, defined by two
hybrid analysis, contains Ime4, Mum2, and a protein known as Slz1 (known as theMIS
complex). Kar4 has also been reported to be included in a complex involving Ime4 and Mum2
(S. Morgan and J. Eugebrecht, Personal Communication). There is not much known about
Mum2 and Slz1, but Mum2 was shown to be a crucial protein for the methyltransferase activity
of Ime4 (Agarwala et al. 2012). Slz1 functions as an accessory protein to further enhance the
catalytic activity of Ime4 (Agarwala et al. 2012).
Mum2 is a protein that is, at least partially, located in the cytoplasm, and it is necessary
for sporulation in Saccharomyces cerevisiae (Davis et al. 2001a). Mum2 can be found in the
13

nucleus as well, where methylation of pre-mRNAs occurs in eukaryotic cells. Also, Mum2
(Muddled Meiosis 2) interacts genetically with Orc2p, which is a protein that is part of the origin
recognition complex (Davis et al. 2001b). Mum2 is a protein with a coiled-coil region located at
its C-terminus that may interact with Ime4 to form a scaffold where other proteins may bind and
further strengthen the activity of the MIS complex (Davis et al. 2001b). Coiled-coil protein
structures are formed by several alpha helical regions in complex with one another (Davis et al.
2001b). Mum2 may also activate Ime4 to perform its catalytic activity, or Mum2 could function
to target Ime4 to mRNA molecules (Agarwala et al. 2012). The importance of Mum2 was
revealed in deletion experiments. When MUM2 was deleted, yeast cells attained sporulation
defects similar to when IME4 was deleted in previous experiments (Agarwala et al. 2012). This
verifies the significance of Mum2 in sporulation. Even more fascinating is when Ime4 is not in
complex with Mum2, Ime4 cannot abundantly modify mRNA transcripts (Agarwala et al. 2012).
The prominence of Mum2 in the MIS complex was verified through these elegant deletion and
mutagenesis experiments.
Slz1, on the other hand, is a sporulation-specific transcription factor that contains a
leucine zipper domain (Agarwala et al. 2012). There is not much known on the direct function of
this protein, but it is a known component of the MIS complex. With its association in the MIS
complex, it appears to strengthen the activity of Ime4 (Agarwala et al. 2012). Through SLZ1
deletion experiments, it has been proven that Slz1 is not a critical component of the MIS
complex (Agarwala et al. 2012). Ime4 is able to methylate adenosine residues in the absence of
Slz1 when overexpressed in mitotic cells. Slz1 may be switched out with other transcription
factors in the MIS complex, but experiments would have to be performed to confirm this
possibility (Personal communication with Dr. Clancy).
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Wt1 and Wtap
Wt1 (Wilms’ tumor 1) and Wtap (Wilms’ tumor associated protein) are important
proteins found in humans. These proteins regulate a variety of functions in the human body.
These proteins interact with one another to carry out their functions. Defects in these proteins
cause major health issues in young children and adults, such as Frasier syndrome, Denys-Drash
syndrome, Wilms’ tumor (embryonal malignancy of the kidney), nephrotic syndrome type 4,
Meacham syndrome, and mesothelioma malignancies (Weizmann Institute of Science 2012).
Wtap and Wt1 proteins are known binding partners. The Wtap protein mostly interacts
with Wt1 when a three amino acid sequence, KTS, is absent from the Wt1 protein sequence
(Little, Hastie, and Davies 2000). Wtap is a protein that is ubiquitously located in the nucleus of
human cells (Horiuchi et al. 2006). Interestingly, Wtap is important for the stabilization of
mRNA transcripts that encode the protein cyclin A2, which is important for G2/M transition
(Horiuchi et al. 2006). The knockdown of WTAP shows a substantial decrease in cyclin A2
mRNA transcripts, and also causes death of 6.5 weeks old rat embryos (Horiuchi et al. 2006).
Also, the knockdown of WTAP leads to an increased activation of cell adhesion, metabolism, and
inflammation (Horiuchi et al. 2006). The importance of this protein may therefore lie in its
regulation of the cell cycle, and possibly the role it plays in its interaction to Wt1.
Wtap has been proposed to be the human ortholog of the yeast protein Mum2, and this
homology indicates that Wtap and Wt1 may be interacting in a larger unknown protein complex
(Agarwala et al. 2012). A homolog of Wtap was also identified in Drosophila melanogaster,
known as Fl(2)d. Fl(2)d is regarded as a splice factor that regulates the alternative splicing of the
sex lethal (SX1) gene (Penn et al. 2008). The splicing of the SX1 gene by Fl(2)d is known to
regulate female specific programs (Penn et al. 2008). Fl(2)d is also known to interact in a protein
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complex as a splicing factor, and this indicated that the human Wtap protein may also interact as
a splice factor in association with a protein complex. Wtap has been observed to associate in
functional human spliceosomes, but how it contributes to the splicing process is a mystery (Penn
et al. 2008). More importantly, strengthening the notion that Wtap may interact in a protein
complex with Mettl3, is the verification that the homolog of Mettl3, known as MT-A in
Arabidopsis thaliana, interacts directly with a homolog of Wtap, known as At FIP37. Evidence
for this is observed in coimmunoprecipation assays that show MT-A and At FIP37 directly
interacting with one another (Zhong et al. 2008). Also, knockout experiments of either MT-A
and At FIP37 resulted in inhibition of embryonic development at the globular stage in
Arabidopsis thaliana (Zhong et al. 2008). These experiments reinforce the notion that Wtap may
interact as a splicing protein, and that Wtap is, in fact, a protein that binds to Mettl3 to regulate
its function and affect cell fate. The experiments to prove the Wtap protein is directly interacting
with Mettl3 is still being carried out by our lab, but what is known is Wtap interacts directly with
Wt1.
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Figure 3: Sequence alignment of MUM2
Wt1 is a protein that is involved in the development of the kidney and the reproductive
organs (Little, Hastie, and Davies 2000). This protein is amazing because it may assume many
functions. Wt1 protein is known to exist in 16 different isoforms (Little, Hastie, and Davies
2000). Yet, how can one protein assume many different roles from a single, primary transcript?
The gene that encodes WT1 may include different types of exons that can alter different
segments of the translated protein. This is a posttranscriptional modification of the encoded WT1
transcript. More specifically, WT1 has two alternating splice sites that encode different versions
of the same protein. One splice site is encoded by exon 5, and if this site is included in the post
modified transcript, it encodes a specific 17 amino acid sequence that may or may not be
included in the final translated protein (Little, Hastie, and Davies 2000). Though not much is
known about the function of the 17 amino acid sequence, it may be a transcriptional repression
domain (Natoli et al. 2002).
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The second alternatively spliced exon includes a lysine, threonine, and serine (KTS)
consecutive sequence which is believed to inhibit the use of Wt1 as a DNA binding protein
(Little, Hastie, and Davies 2000). This is because Wt1 has a zinc finger binding domain, which is
used to bind DNA, that the KTS sequence hinders (Little, Hastie, and Davies 2000).
Interestingly enough, many of the functions that Wt1 performs must incorporate the interaction
of other proteins. Wt1 may also act as a transcription factor, but only if other proteins interact
with Wt1 to allow it to carry out its function (Little, Hastie, and Davies 2000). Wt1 may also act
as a posttranscriptional regulator, may play a role in splicing, and it may have a role in cell cycle
regulation (Natoli et al. 2002). Through the use of yeast-two hybrid experiments, scientists have
discovered that Wtap and Wt1 are definite binding partners (Little, Hastie, and Davies 2000).
These proteins may also interact in an unknown protein complex. The importance of this
interaction is still unknown.
Protein complexes
An explanation of protein complexes segues into the experimental approaches we have
taken to understand how the MIS complex functions, and to discover new unknown proteins that
may be associated with the MIS complex.
A protein complex is a single functional system consisting of multiple proteins that may
assume different functions but all work to strengthen the activity of a central protein in the
complex. The proteins that function as a single unit may interact transiently or stably. As
mentioned, not much is known of the MIS protein complex. It is known that the proteins that
function in this complex strengthen the function of Ime4, which methylates adenosine residues
on pre-mRNA transcripts. Also, we believe that the homolog of Ime4, known as Mettl3, may
function in a protein complex similar to the MIS complex. The homology between Ime4 and
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Mettl3 strengthens this hypothesis. Also, we hypothesize that the homolog of Mum2 (Wtap) may
be a binding partner in the proposed Mettl3 binding complex.
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Materials and Methods
Materials
Primers were designed in lab and sent to Integrated DNA Technologies for their
synthesis. Strataprep plasmid miniprep kits (The catalog number for the kit is 400763),
Strataprep PCR purification kits (The catalog number for the kit is 400771), XL1-Blue
competent and subcloning competent cells used for Escherichia coli transformations, GAL4
Two-Hybrid Phagemid Vector kits, and high fidelity Herculase II fusion Pfu polymerase used for
PCR amplifications were purchased from Agilent/Stratagene Technologies. Most of the
restriction enzymes, Taq polymerase, and their associated buffers were purchased from Promega.
Some restriction enzymes, the T4 DNA Ligase, and their associated buffers were purchased from
New England Biolabs.
Media used for Transformations and Cell Cultures
For E. coli transformations and streakings, we used Luria broth (LB) media. This media
was made using 1.5% agar (0.015 g/ml), 1% bacto-tryptone (0.01g/ml), 0.5% yeast extract
(0.005 g/ml), 0.5% NaCl (0.005 g/ml), and adjusted to a pH of 7.5. Accordingly, antibiotic
resistance was included in the media depending on the requirement of the specific plasmid that
was used. The antibiotics used were either ampicillin (100 µg/ml) or chloramphenicol (30
µg/ml). LB liquid media used for cultures include the aforementioned ingredients excluding the
agar.
For yeast transformation and culture maintenance, a variety of media was used. Yeast
extract peptone dextrose (YEPD) was used to streak and culture yeast colonies. This media
included all the necessary supplements that yeast cells require for survival. Ingredients used to
make this media include 1% yeast extract (0.01 g/ml), 2% peptone (0.02 g/ml), 2% dextrose
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(0.02 g/ml) , and 2% agar (0.02 g/ml) for plating. Liquid YEPD requires the above mentioned
ingredients excluding the agar.
Nutrient limiting media was used for plasmid selection of transformed yeast. This media
is known as synthetic complete (SC) media. The ingredients used to create this media include
10X Bacto-yeast nitrogen base (YNB) without amino acids (0.067 g/ml), 5X dropout mix (0.01
g/ml) , 2% dextrose (0.02 g/ml), 2% bacto-agar (0.02 g/ml), and the supplemental amino acids
which include: 5 mls leucine (10 mg/ml), 5mls tryptophan (10 mg/ml), 5 mls histidine (10
mg/ml), 10 mls uracil (2 mg/ml), 5 mls adenine (4 mg/ml), 5 mls lysine (10 mg/ml), and 5 mls
methionine (10 mg/ml). The synthetic dropout mix without YNB was purchased from U.S
BioLogical and does not contain adenine, histidine, leucine, tryptophan, and uracil.
Primer Construction
Primers were designed in lab and purchased from IDT according to the gene we were
interested in amplifying for cloning or verification purposes. The amount of oligo we received
from IDT was usually approximately 20 nmoles, and was delivered in the form of dry powder.
Also, the oligos were desalted before they arrived. Forward and reverse primers were created by
specific sequences found on the genes we used. The forward primer was a copy of the beginning
of the gene to be amplified or the beginning of the section of the gene to be amplified (5’ end of
the gene). The reverse primer needed to be copied from the end of the gene or specific region of
the gene to be amplified. Then, the reverse primer needed to be complemented with its necessary
bases, and was written in reverse. Primers used for cloning incorporated restriction sites that
coincided with the restriction sites located on the vector to which the gene was ligated. Also,
extra bases were added or removed to put the gene in frame with the GAL activation or the GAL
binding domain encoded by the vector, so the incorrect protein was not translated when a yeast
21

two hybrid experiment was performed. We used the restriction sites on the ligated plasmid which
verified a ligated gene was cloned to its correct vector. Restriction enzymes knicked the genes at
the junction sites and dropped the gene from its vector. An agarose gel was used to view the
restriction digested DNA.
Primers used for cloning are shown in the table below:
Gene or Gene

Forward Primer Sequence

Reverse Primer Sequence

Fragment Identity

5’→3’

5’→3’

pAD 745-765

TTTTTCTCGAGATGTCTGCTA
CATCTTCA
TTTTGAATTCATGATTAACGA
TAAATCA
TTTTGAATTCATGATTAACGA
TAAACTA
TTTTGAATTCCACCCAGGATT
AATTGAGTGCATTCAA
TTTTGAATTCGATTCGGAAAA
AGACCAA
TTTTCCCGGGGAATGTCGGAC
ACGTGGAGCTCTATC
TTTTGAATTCTGTGACTATGG
AACCAAGGAGGAG
TTTTTAGATCATATATGAATT
ACATGGCT
AGGGATGTTTAATACCACTAC

TTTTGTCGACTTATATTTTAGG
TTTTTTGGCATCTGG
TTTTGTCGACCTGAGCAAAAT
ATAGGTT
TTTTGTCGACATGTGCGGAGC
AATTGCC
TTTTGTCGACTTACTGTGCAA
AATATAGGTTATTTAG
TTTTGTCGACGGATATTTTGG
ACCATTG
TTTTGTCGACCTATTGATAATT
CGTCTGAAGTGCAGC
TTTTGTCGACCTATAAATTCTT
AGGTTTAGAGAT
TTTTTGTCGACTCAATTAGCA
ACGTCC
N/A

pBD 816-836

GTGCGACATCATCATCGGAAG

N/A

WT1

TTTTGAATTCGAGAAGGGTTA
CAGCACGGTC
TTTTTGAATTCACCAACGAAG
AACCTCTTCCC
ATTTGGATCCATGCAGAAGTG
TGCTGGC

TTTTGTCGACCTAAAGCGCCA
GCTGGAGTTTGGT
AAAAGTCGACTTACAAAACTG
AACCCTGTACATT
ATTTGTCGACTTAATTGTTCTC
ATTTTCAAAGTC

BUR2
IME4 1-600
IME4 1-316
IME4 231-600
IME4 131-225
METTL3 1-302
METTL3 273-580
MUM2

WTAP
YGL036W

Plasmids purchased for cloning:
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Plasmid Identity
pAD-GAL4-2.1 vector
pBD-GAL4 Cam
vector

Accession #/
Manufacturer
AF033313.1/
Stratagene
U46126.1/ Sratagene

Plasmid Created by : Transformation
Markers
Stratagene
LEU2, Ampr
TRP1,Camr

Stratagene

Plasmids created for transformations:
Plasmid Identity
BUR2-GAL4AD
IME4 1-600GAL4BD
IME4 1-316GAL4BD
IME4 231-600GAL4BD
IME4 131-225GAL4BD
METTL3 1-302GAL4BD
METTL3 273-580GAL4BD
MUM2-GAL4AD

WT1- GAL4AD
WTAP- GAL4AD/
WTAP- GAL4BD
YGL036W- GAL4AD

Accession #/
Manufacturer
DAA09542.1/ Open
Biosystems
P41833.1/ Clancy Lab

Plasmid Created by : Transformation
Markers
Jenisha Ghimire
LEU2, Ampr
TRP1,Camr

P41833.1/ Clancy Lab

Sanjeev Dahal and
Pinithi Perrera
Sanjeev Dahal and
Pinithi Perrera
Mary Clancy

P41833.1/ Clancy Lab

Sanjeev Dahal

TRP1,Camr

BC001650.2/ Clancy
Lab
BC001650.2/ Clancy
Lab
CAA85000.1/ Clancy
Lab

Yazan Alqara

TRP1,Camr

Yazan Alqara

TRP1,Camr

Mary Clancy

LEU2, Ampr

BC032861.2/ Clancy
Lab
BC069192.1/ Clancy
Lab
P53185.1/ Clancy Lab

Yazan Alqara

LEU2, Ampr

Yazan Alqara/ Yazan
Alqara
Yazan Alqara and
John Williamson

LEU2 ,Ampr/
TRP1,Camr
LEU2, Ampr

P41833.1/ Clancy Lab

TRP1,Camr
TRP1,Camr

Strain used for Yeast Two Hybrid assays:
Strain
YRG-2a

Genotype
MATα ura352 his3-200 ade2-101
lys2-801 trp1-901 leu2-3 112
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Reporter
Gene
lacZ, HIS3

Transformation
markers
leu2, trp1, his3

gal4-542 gal80-538
LYS2::UASGAL1-TATAGAL1HIS3 URA3::UASGAL4 17mers(x3)TATACYC1-lacZ
(Table copied from GAL4 Two-Hybrid Phagemid Vector Kits Instruction manual)
Restriction Digests
Restriction digests were used for verification that a gene had been cloned correctly, and
was used to create the ends of vectors and inserts for cloning purposes. A typical restriction
digest consisted of a mixture of restriction enzymes, their associated buffers, and the DNA that
was used for cloning or verification purposes, in a 20 microliter total volume. A reaction
included 2 microliters of 10X enzyme buffer provided by the supplier for optimal activity of the
restriction enzyme. If two restriction enzymes were used in one 20 microliter mixture then one
buffer that optimized the activity of both enzymes was used. The amount of sterile water used
was variable, depending on the amounts of DNA and enzyme used. Typically, 0.5-1 microliter of
enzyme was used (about 10 units of enzyme per microliter). The amount of DNA used was about
<1000ng of DNA, and the amount of water used was between 11 and 14 microliters. Reactions
were incubated at 37 degrees Celsius for approximately one hour for optimal enzyme activity.
Polymerase Chain Reaction
The PCR amplification technique was used to amplify specific genes from their vectors.
First, the vector in which the gene is enclosed was linearized using the appropriate restriction
enzyme. Second, a mixture was made that included the required polymerase (2 units of Pfu or
Taq polymerase), its 5X associated buffer (10 microliters), forward and reverse primers for the
gene of interest (50-100 pmol), deoxyribonucleotide triphosphates (200 µM of dNTPs), the DNA
of interest (<1000 ng), and sterilized water to a total volume of 50 microliters. Finally, this
mixture was put into the PCR machine at variable temperatures. For the first step (initial
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denaturation) the mixture was heated to 95 degrees Celsius for 5 minutes. The second step is the
first denaturation which was set for 95 degrees Celsius for a time between 15-40 seconds. The
third step is the annealing step, which was set at 45-60 degrees Celsius for a time between 30-60
seconds. The fourth step is the extension step, which was set at 60-72 degrees Celsius for a time
that corresponded with the length of the DNA (2minutes/kb for Pfu and 1 minute/kb for Taq).
The final step is the final extension step which was set at 72 degrees Celsius for 5 minutes. Steps
2-4 were repeated for 30 cycles.
PCR Purification
Minicolumns were used to purify DNA following a PCR or restriction digest to be used
for cloning purposes. This kit includes a microspin cup with a filter that retains DNA equal to or
greater than 100 bp. Also the kit includes wash buffer and DNA binding solution. DNA obtained
from PCR amplification or restriction digests were mixed with equal volumes of DNA binding
solution. The DNA binding solution and DNA mixture was transferred into a filtered microspin
cup that was centrifuged (14,000 rpm) for 30 seconds. This separated the DNA binding solution
from the DNA of interest. 750 microliters of wash buffer mixed with ethanol was added to the
microspin cup and centrifuged in a microfuge for a maximum of 30 seconds to separate the wash
buffer from the DNA. Then 1X TE was added to the column and incubated for 5 minutes. The
microspin cup was then centrifuged as above to elute the purified DNA.
Plasmid Purification from E. coli
Transformed plasmids from E.coli competent cells were purified using Strataprep
plasmid miniprep kits. We used the protocol that came with the miniprep kit. It includes solution
1, solution 2, solution 3, wash buffer, microspin cups, and 2 ml receptacle tubes. These solutions
were used to break the cells, in order to extract the plasmid DNA and then to bind the DNA.
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After cell lysis and centrifugation for a maximum of 5 minutes, the supernatant was transferred
to a plasmid purification column (microspin cup seated in a 2 ml receptacle tube). Once the
supernatant was added to the column, it was centrifuged for a maximum of 30 seconds. This
separated the solutions from the plasmid DNA. Wash buffer was then added and separated from
the DNA in the filter column; this assured the DNA was purified. Finally, 1X TE was added to
the filter column, and left to incubate for 5 minutes at room temperature. The purified plasmid
DNA was eluted with 1X TE.
Cloning procedure
Cloning is an experiment used to create a fusion protein by using an insert and a vector of
choice. The cloning procedure requires many steps and is very involved. Many of the steps
required involve the aforementioned methods, and since these methods were already explained in
sections above, I have summarized the cloning procedure as much as possible. PCR
amplification was required to obtain large quantities of insert that was used for the ligation. Once
large quantities of insert were obtained, the DNA was purified as much as possible using the
Strataprep PCR purification kit. Following the PCR purification, separate restriction digests were
run on the amplified insert and on the vector in which the insert was ligated. The restriction
digest was to ensure that the ends of the insert and vector were compatible and able to ligate to
one another. After the restriction digest, another purification procedure (using the Strataprep
PCR purification kit) was required to ensure that the vector and insert were purified. If any
restriction enzymes remained in the insert or vector mixtures the ligation procedure was inhibited
due to continuous cutting by the enzyme. To make sure no residual enzymes remained after the
purification, the vector and insert were placed on the heating block at 65 degrees Celsius for 20
minutes. This denatured any residual enzymes and deactivated its activity.
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After the vector and insert were placed on the heating block, a gel was run to verify the
DNA had not vanished, and also guaranteed that the bands coincided with the correct number of
base pairs that the vector and insert contained. Also, a gel was used to estimate the amounts of
vector and insert used for the ligation procedure. Usually, while the gel ran, we used the
nanodrop instrument to quantify the amount of DNA present in both the vector and insert
mixture. The nanodrop instrument measured the absorbance of the DNA mixture at 260 nm and
the determined amount of DNA in nanograms per microliter. With this data, we calculated the
exact amount of DNA used in the ligation mixture. Also, if the correct bands were viewed on the
gel, the ligation was not abandoned. If bands were not observed on the gel, it was a good
indicator that the correct DNA was not present, and the cloning procedure was redone.
After calculating the amount of DNA, based on the data obtained from the nanodrop and
gel analysis, the ligation was ready to be performed. The mixture contained a T4 DNA ligase, its
10X associated buffer, vector, insert, and sterilized water. The total volume used for our ligations
was 40 microliters. The amount of 10X T4 DNA ligase buffer used was 4 microliters, and the
amount of other components used in a ligation mixture was usually variable. The amount of T4
DNA ligase used was usually between 0.5 -1 microliter (400 units/µl). The amount of water
used depended on the calculated amount of vector and insert used. After the mixture was created,
it was incubated at room temperature for one hour. After this incubation period, the mixture was
doubly incubated in a Styrofoam box filled with water at room temperature and put in the 4
degree Celsius fridge overnight. This is so the ligase had the opportunity to be active at many
different temperatures because we were not sure of the temperature it reached its optimal
activity. Once this incubation period was over, the ligation mixture was used for E. coli
transformations on the correct antibiotic media (depended on the antibiotic resistant marker
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found on the associated vector) and we retrieved the correct ligated plasmid. We found the
correctly ligated plasmid by culturing many colonies from the E. coli transformation,
miniprepped the cultured colonies to purify the recombinant DNA, used a restriction digest to
drop the insert from the vector, and ran the restriction digested DNA on a gel that verified that
the insert had dropped from the vector.
E. coli Transformation
E. coli transformations were done to produce sufficient plasmid DNA. These
transformations were performed after cloning so cells procured the recombinant DNA and
produced sufficient DNA used for future experiments. The colony was cultured and
miniprepped, respectively. The transformation began by thawing XL1-Blue competent or subcloning competent cells. The sub-cloning grade competent cells (Stratagene) were used for quick
transformations, but ultimately led to less efficient acquisition of the recombinant plasmid. The
super-competent E. coli cells more efficiently acquired the transforming DNA, but required
longer incubation times and used β-mercaptoethanol. β-mercaptoethanol was shown to increase
transformation efficiency. I have explained the procedure for the sub-cloning competent cells for
ease of understanding.
Once the cells were thawed, 50 microliters of cells were added to a 14 ml “Falcon” tube.
After this, 0.1-50 ng of DNA was added to the 50 microliters of competent cells and incubated
on ice for 20 minutes. Following the incubation period, the mixture was heat-pulsed for 45
seconds in a water bath that was 42 degrees Celsius. The duration of the heat-pulse was critical.
The tube was then incubated on ice for 2 minutes. Then 0.9 ml of SOC (1ml of liquid LB media,
100 microliters of 2M MgSO4, and 200 microliters of 20% glucose) medium was added to the
competent cells mixed with plasmid DNA. The SOC, sub-cloning competent cells, and
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recombinant DNA mixture was incubated at 37 degrees Celsius for 30 minutes with shaking at
about 200 rpm. Afterwards, the mixture was plated on solid LB media with the correct antibiotic
according to the antibiotic marker the plasmid contained. Usually, 100-200 microliters were used
for each LB plate. Incubation overnight at 37 degrees Celsius was required for appearance of
colonies.
Yeast Transformations
Yeast transformation experiments were used to transform plasmids into yeast that were
obtained from E. coli transformations or bought directly from a manufacturer. The transformed
plasmid contained an amino acid marker that yeast cells required for viability. Before the actual
transformation began, yeast colonies were cultured in liquid YEPD (usually 5 mls) and incubated
at 30 degrees Celsius overnight. The yeast culture was robust so the yeast transformation was
efficient. Once the yeast culture was done incubating, it was diluted in 45 mls of liquid YEPD.
This gave us a 1:10 dilution so the cells did not overgrow when transformed. The diluted yeast
cells were incubated for 1-4 hours. Following the incubation, the yeast cells were centrifuged in
a desktop centrifuge for 15 minutes, washed with 10 mls of sterile water, re-centrifuged, and
centrifuged again in an ultra-centrifuge for 5 minutes at room temperature. The cells were then
re-suspended in 1ml sterile water and transferred to a 1.5 ml microfuge tube.
The cells were centrifuged, and the supernatant was discarded. A 1X TE/LiOAc solution
(1ml 10X TE pH 7.5, 1ml 1M lithium acetate and 8 mls sterile water) was made to resuspend the
cells, and then the cells were centrifuged once again. The yeast cells were re-suspended in 0.25
mls of 1X TE/LiOAc solution. Then, 50 microliters were transferred to a different microfuge
tube in which 5 microliters of carrier DNA (10 mg/ml) and transforming DNA were added. After
this, a polyethylene glycol solution (4 mls 50% PEG, 0.5 ml 10X TE, 0.5 ml 10X LiOAc, and
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equilibrated to a pH of 7.5) was made and 300 microliters was added to the transformed and
carrier DNA yeast mixture. The mixture was incubated at 30 degrees Celsius for one hour, and
after, 40 microliters of DMSO was added to increase transformation efficiency. The mixture was
then heat shocked at 42 degrees Celsius for 15 minutes. Then the cells were washed and
centrifuged in 1X TE. The cells were then resuspended in 1ml of 1X TE and 200 microliters
were plated on solid selective media according to the plasmid used. The plates incubated for
about 3 days at 30 degrees Celsius, or until colonies were fully grown. This high efficiency yeast
transformation was performed according to the Linda Hoskins/Hahn Lab protocol
(http://labs.fhcrc.org/hahn/Methods/genetic_meth/dmso_yeast_transform.html).
Yeast-Two Hybrid to Test for Protein Interactions
The Yeast-Two Hybrid analysis is used to test for protein interactions (Molecular Cell
Biology 2000). Two specific plasmids were used for this experiment. The pAD-GAL4-2.1 vector
contains an ampicillin resistance marker for E. coli transformations, the LEU2 gene for selection
in yeast transformations, and DNA encoding the activation domain of GAL4 for protein
interaction. The pBD-GAL4 Cam vector contains a chloramphenicol resistance marker, TRP1
gene for selection, and DNA encoding the binding domain for protein interactions. Both
plasmids contain a multiple cloning site where several restriction sites are found for cloning
purposes. Before these plasmids were used for any transformation, the gene of interest (insert)
was first ligated into these vectors, according to the cloning procedures previously explained.
Then these recombinant plasmids were transformed into E. coli for overexpression of the
plasmids, as explained in the E.coli transformation section. After the E. coli transformation, the
plasmids were miniprepped and used for yeast transformations (as explained in the sections
above).
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The recombinant plasmids were transformed into the YRG-2 yeast strain, which contains
HIS3 and the Lac Z reporter gene driven by GAL4 binding sites to assess verified in vivo protein
interactions. Also, the YRG-2 strain carries a mutation which ensures that the GAL4 gene is not
expressed. Similarly, the YRG-2 strain carries leucine and tryptophan auxotrophic markers to
verify that the GAL AD and the GAL BD recombinant vectors are transformed into the YRG-2
strain. The YRG-2 strain also has a histidine auxotrophic marker to select for in vivo protein
interactions. The HIS3 gene is only activated if the fusion proteins interact with one another. The
Lac Z assay may also be used to test for protein interactions quantitatively.
The GAL AD and the GAL BD vectors were transformed simultaneously using the yeast
transformation procedure explained in the previous section. To verify these plasmids were
correctly transformed, the transformed cells were plated on SC solid media plates that did not
contain leucine and tryptophan. Growth indicated that the cells contained the correct GAL AD
and GAL BD vectors. These vectors should also contain the correct inserts which were translated
in yeast cells to their protein products. The yeast cells that grew on the -leu,-trp plates were then
patched onto SC plates that did not contain leucine, tryptophan, or histidine. If the cells grew on
these plates, there was a protein interaction occurring. This experiment was done multiple times
to acquire my results and to verify the results as well.
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Results
Cloning the IME4 gene and its fragments to test for specific protein-protein interactions
The IME4 full length (amino acids 1-600) gene, the IME4 N- terminal (amino acids 1316) fragment, the IME4 C-terminal (amino acids 231-600), and the IME4 leucine (amino acids
131-225) rich fragment were cloned into the GAL 4 binding domain of plasmid pBD-GAL4 Cam
using the EcoRI and SalI restriction sites located on the GAL 4 binding domain vector to test for
protein interactions. The IME4 gene and its aforementioned fragments were amplified using
primers (see Materials and Methods section for specific sequence of primers) that contained
EcoRI and SalI restriction sites that were used to ligate these inserts to the restricted vector,
which contained the compatible sites as well. The purified PCR products were ligated to the
pBD-GAL4 Cam vector to create in-frame protein fusions to the Gal 4 binding domain.

Figure 4: A representation of the fragmented inserts of IME4 within the GAL4 binding domain.
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Test for Auto activation of IME4 and its associated fragments
The N-terminal Ime4 fragment was seen to auto activate when transformed into YRG-2
yeast strains with the empty pAD-GAL4-2.1 vector for yeast two hybrid assays. The empty pBDGAL4 Cam vector, full length, leucine rich, and catalytic regions of Ime4 did not auto activate
when transformed with the empty pAD-GAL4-2.1 vector. By this notion, we did not use the
Ime4 N-terminal in the yeast two hybrid assays because it would have given us false positives for
any pAD-GAL4-2.1 vector with its associated insert. Also, we strongly believe that the HIS3
reporter gene is leaky in certain transformations and has resulted in the slight increase of growth
in the YRG-2 strain when transformed with Ime4 full length and an empty activation domain
vector. We sequenced these bait plasmids and verified that all of them were correctly cloned and
in frame. The reason the IME4 insert is used in the “bait” plasmid (binding domain) is because
we are interested in validating novel protein interactions.

a

c

b

e

d
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Figure 5: a. pAD-GAL4-2.1 transformed with pBD-GAL4 Cam vector. b. Ime4 N-terminal (1316) in pBD-GAL4 Cam transformed with empty pAD-GAL4-2.1. c. Ime4 Full (1-600) in pADGAL4-2.1 vector transformed with pBD-GAL4 Cam. d. Ime4 Catalytic region (231-600) e. Ime4
Leucine rich region (131-225) in pBD-GAL4 Cam transformed with pAD-GAL4-2.1.

Motivation to study Mum2 protein interactions
Mum2 and Ime4 were verified to interact with one another in a protein complex by the
Fink Lab (Agarwala et al. 2012). This protein complex is referred to as the MIS complex
(Mum2, Ime4, and Slz). Mum2 is an essential protein in the MIS complex, and its interaction
with Ime4 is crucial for Ime4 to carry out its catalysis. Deletion experiments of the MUM2 gene
resulted in sporulation defects in Saccharomyces cerevisiae because of the consequent down
regulation of Ime4 (Agarwala et al. 2012). Mum2 is essential for the catalytic activity of Ime4.
We were interested in understanding the exact location of Mum2 binding with the Ime4 protein,
and we used the fragments of IME4 to ascertain the sequence to which Mum2 binds to Ime4.
Cloning the MUM2 gene
The MUM2 gene was cloned into the GAL4 activation domain (AD) vector as the “prey”
protein and we assessed its specific interaction with the IME4 gene and its fragments, which
were considered the bait “proteins” in yeast two hybrid experiments. The restriction sites used in
the PCR amplification of the MUM2 gene were EcoRI and a BamI/BglII junction. The
BamI/BglII junction was used because ligating the MUM2 gene into the GAL 4 activation
domain proved to be difficult with the use of other restriction sites.
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IME4 full 1-600

Lane 4
Lane 5

IME4 N-terminal 1316
IME4 231-600
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Lane 7

GAL BD (control)
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Figure 6: A restriction digest was performed on MUM2 in its GAL4 activation domain vector
which showed that MUM2 was correctly ligated. Also, restriction digests were performed on
IME4 and its associated fragments that were ligated to the GAL4 binding domain. The GAL
binding domain vector is 6.5 kb, the GAL4 activation domain vector is 7.0 kb, the MUM2 insert
is 1.1 kb, the IME4 full length insert is 1.8 kb, the IME4 N-terminal is 0.95 kb, the IME4
catalytic region is 1.1 kb, and the IME4 Leucine rich segment is 0.28 kb. Also, we sequenced the
fusion plasmid and verified the clone was in frame.

Mum2 and Ime4 Protein-Protein interactions
By using the yeast two hybrid assays, the cloned MUM2-GAL 4 activation domain and
the IME4 full length-GAL 4 binding domain, with its fragments as well, were simultaneously
transformed into YRG-2 yeast cells and plated on SC media that were lacking leucine and
tryptophan to select for the two plasmids. The yeast cells present on the leucine and tryptophan
deficient SC media grew for about three days before being patched onto leucine, tryptophan, and
histidine deficient media to observe activation of the Gal 4 dependent HIS3 reporter in the strain.
We patched the yeast cells on this media and verified that Mum2 and Ime4 full interacted. We
further investigated the interaction between Ime4 and Mum2.
Analogous experiments were completed with the Ime4 fragmented proteins and the
Mum2 protein. We demonstrated that the Ime4 catalytic region (amino acids 231-600) did not
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interact with the full length Mum 2 protein. The Ime4 N-terminal (amino acids 1-316) displayed
an interaction with Mum2, but this result remains inconclusive because we validated that the Nterminal domain of Ime4 is auto activated in yeast two hybrid assays. We zoomed in on a leucine
rich region located in the N-terminal of the Ime4 protein, which did not auto-activate in previous
yeast two hybrid experiments. We termed this region the Ime4 leucine rich region, extending
from amino acids 131-225 of the Ime4 protein. Interestingly, Mum2 interacted directly with the
Ime4 Leucine rich region in yeast two hybrid assays. This led us to believe that the interaction
between Mum2 and the Ime4 Leucine rich region may be even more specific. Presently, we are
conducting experiments that will narrow down the interaction between Mum2 and the Ime4
leucine rich region.
Motivation to study Ygl036w protein interactions
Previous affinity capture and yeast two hybrid experiments have suggested that Ygl036w
and Mum2 exhibit protein-protein interactions (TylersLab.com 2013). YGL036W is not an
essential gene, and its function is unknown (TylersLab.com 2013). These interactions have
implications that Ygl036w may interact with Ime4.
Cloning the YGL036W gene
The YGL036W gene was cloned into the GAL4 activation domain vector using BamHI
and SalI restriction sites that were incorporated into the primers. The YGL036W-GAL4
activation domain fusion protein was transformed into YRG-2 yeast cells simultaneously with
the IME4 full length and fragments of IME4 that were cloned into the GAL4 binding domain
vector as above. This was done to investigate the interaction between Ygl036w and the Ime4
protein, including its associated fragments.
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Figure 7: A restriction digest was performed on YGL036W in its GAL4 activation domain vector
which showed that YGL036W was correctly ligated. Also, restriction digests were performed on
IME4 and its associated fragments that were ligated to the GAL4 binding domain. The GAL
binding domain vector is 6.5 kb, the GAL4 activation domain vector is 7.0 kb, the YGL036W
insert is about 2.7 kb, the IME4 full length insert is 1.8 kb, the IME4 N-terminal is 0.95 kb, the
IME4 catalytic region is 1.1 kb, and the IME4 Leucine rich segment is 0.28 kb. Also, we
sequenced the fusion plasmid and verified the clone was in frame.

Ygl036w and Ime4 Protein-Protein interactions
Though virtually nothing is known about the Ygl036w protein, we decided to test
whether or not Ime4 interacts with this protein. We were able to confirm that the full length Ime4
protein does interact with the Ygl036w protein.
In discovering that the Ime4 full length protein and the Ygl036w protein interacted, we
decided to do similar experiments that were done with the Mum2 protein, which narrowed down
the interaction between Ime4 and Mum2 to specific leucine residues. The Ime4 catalytic region
displayed no interaction with Ygl036w, and this result was consistent with those seen for all
“prey” proteins. We then decided to test whether the leucine rich region of Ime4 interacted with
Ygl036w, which Mum2 was verified to interact with. This experiment was inconclusive because
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it interacted very weakly with the Ime4 leucine rich region. We believed that the HIS3 reporter
gene in the YRG-2 strain could be leaky when yeast two hybrid assay experiments are carried
out. Further experimentation will be done to assess the results between the leucine rich region of
Ime4 and Ygl036w.

a

b

Figure 8: a. Ygl036w in the pAD-GAL4-2.1 vector transformed with Ime4 Full in the pBDGAL4 Cam vector. b. Ygl036w in the pAD-GAL4-2.1 vector transformed with empty pBDGAL4 Cam vector.

Motivation to study Bur2 protein interactions
Bur2 is a cyclin for the Sgvp1 (Bur1) protein kinase, and they comprise a CDK-cyclin
complex that is involved in transcriptional regulation (Yao, Neiman, and Prelich 2000). The
regulation of transcription through this complex is controlled by phosphorylation of the carboxyterminal domain of the largest subunit of RNA polymerase II (Yao, Neiman, and Prelich 2000).
Fascinatingly, Bur2 used as the bait protein in yeast two hybrid analysis and Ime4 used as the
prey protein was found to interact in two independent studies (Malmström et al. 2007). The
function of this interaction is still unclear, and it was in our best interest to find out the specific
interaction between these two proteins. This may further elucidate the function of Bur2 in the
MIS complex.
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Cloning the BUR2 gene
The BUR2 gene was cloned using restriction sequences that were added to the specific
BUR2 primer sequences. The restriction sequences are SalI and XhoI. We amplified this gene
using the specific forward and reverse primers and cloned the insert into the GAL4 activation
domain vector, which had compatible restriction sites.
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BUR2 AD

Lane 2

GAL AD (control)

Lane 3

IME4 full 1-600

Lane 4

IME4 N-terminal
1-316

Lane 5

IME4 231-600

Lane 6

GAL BD (control)

Lane 7

LADDER

Figure 9: A restriction digest was performed on BUR2 in its GAL4 activation domain vector
which showed that BUR2 was correctly ligated. Also, restriction digests were performed on
IME4 and its associated fragments that were ligated to the GAL4 binding domain. The GAL
binding domain vector is 6.5 kb, the GAL4 activation domain vector is 7.0 kb, the BUR2 insert is
about 1.2 kb, the IME4 full length insert is 1.8 kb, the IME4 N-terminal is 0.95 kb, the IME4
catalytic region is 1.1 kb, and the IME4 Leucine rich segment is 0.28 kb. Also, we sequenced the
fusion plasmid and verified the clone was in frame.

Bur2 and Ime4 protein-protein interactions
Yeast two hybrid screens were prepared to test the interaction between the Ime4 full
length protein and the Bur2 protein. We used Bur2 as the prey protein and Ime4 as the bait
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protein in our yeast two hybrid assays, which opposed the two independent previous
experiments. Our results were similar; we found that the Bur2 protein and the Ime4 full length
protein interacted. We replicated the Ygl036w experiments to acquire a clearer representation of
the specific interaction between Bur2 and Ime4.
Bur2 and the catalytic region of Ime4 were screened for interactions. We discovered that
Bur2 and the Ime4 catalytic region did not interact when coupled in yeast two hybrid screens.
The catalytic region of Ime4 seems to be absent of protein binding. This is why we are convinced
that all the aforementioned proteins interact in the N-terminal portion of Ime4. To further
convince us that Bur2 does not interact in a similar manner to Mum2, we tested the interaction
between Bur2 and the leucine rich region of Ime4. These fusion proteins did not interact with
one another in our yeast two hybrid screens.

a

b

Figure 10: a. Bur 2 in the pAD-GAL4-2.1 vector transformed with Ime4 Full in the pBD-GAL4
Cam vector. b. Bur 2 in the pAD-GAL4-2.1 vector transformed with empty pBD-GAL4 Cam
vector.
Cloning the METTL3 gene and its fragments to test for specific protein-protein interactions
We tried numerous times to clone the full length METTL3 gene, but it proved to be
difficult. We tried many different restriction sites in association with the restriction sites found in
the GAL4 binding domain, but nothing seemed to work. We considered that the fusion protein of
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the full length Mettl3 protein could be toxic in E.coli cells when transformed following a ligation
(Personal Communication with Dr.Clancy). But even this conclusion could be debated because
the ligations could have been erroneous in some manner (Personal Communication with
Dr.Clancy). We decided the best scenario would be to clone half segments of the protein to test
for interactions using the yeast two hybrid screens.
METTL3 amino acids 273-580 was cloned into the pBD-GAL4 Cam vector using EcoRI
and SalI restriction sites that were compatible with restriction sites situated in the multiple
cloning site of the GAL4 binding domain vector. The primers (specific primer sequences can be
viewed in the Methods section) contained the restriction sequences that were needed to create the
flanking restriction sites for the METTL3 273-580 insert. The METTL3 fragment was cloned into
the pBD-GAL4 Cam vector known as the bait plasmid because we were interested in observing
its interaction with different proteins. The genes we used to test protein interactions with Mettl3
were cloned into the pAD-GAL4-2.1 vector, which is considered the “prey” plasmid.
Motivation to study Wtap protein interactions
We postulated that the Wtap protein would interact with the Mettl3 protein because of
their orthology to the yeast proteins Mum2 and Ime4, respectively. Furthermore, Mettl3 has been
suggested to carry out its catalysis in a protein complex (Bokar et al. 1997). The elucidations of
the proteins that interact in the Mettl3 complex are still being investigated.
Cloning the WTAP Gene
The WTAP gene was cloned into both the GAL4 activation and binding domain vectors.
The restriction sites flanking the WTAP inserts were EcoRI and SalI. Only one pair of forward
and reverse primers (specific sequences found in Materials and Methods section) with these
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restriction sequences were required to successfully clone the WTAP inserts into their respective
vectors. Once cloned, these plasmids were used for yeast two hybrid screens.
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IME4 Nterminal
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(control)
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LADDER

Figure 11: A restriction digest was performed on WTAP in its GAL4 activation domain vector
which showed that WTAP was correctly ligated. Also, restriction digests were performed on
IME4 and its associated fragments that were ligated to the GAL4 binding domain. The GAL
binding domain vector is 6.5 kb, the GAL4 activation domain vector is 7.0 kb, the WTAP insert
is about 1.2 kb, and the IME4 N-terminal is 0.95 kb Also, we sequenced the fusion plasmid and
verified the clone was in frame.

Wtap protein interacting with itself
We did experiments that showed Wtap interacting with itself. The WTAP gene was
cloned into the binding and activation domain plasmids, and then we transformed the plasmids
simultaneously into the YRG-2 yeast strains. We then did a yeast two hybrid assay and
discovered that Wtap does interact with itself. Also we did controls to verify that Wtap did not
auto-activate. The results are shown in Figure 12.
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Figure 12: a. Wtap in the pBD-GAL4 Cam vector transformed with Wtap in the pAD-GAL4-2.1
vector to test for their interaction. b. Wtap in the pAD-GAL4-2.1vector transformed with empty
pAD-GAL4-2.1 vector as a control to ensure that it did not auto-activate. c. Wtap in the pADGAL4-2.1vector transformed with empty pBD-GAL4 as a control to ensure that it did not autoactivate.
Wtap and Mettl3 273-580 protein interaction
Experiments were performed to test the interaction between Mettl3 amino acids 273-580
and Wtap in the pAD-GAL4-2.1vector. We suspect that these proteins are interacting because of
the growth on the plates shown in Figure 13. These protein interactions will have to be verified
using coimmunopercipitation assays.

a

b

c

Figure 13: a. Mettl3 amino acids 273-580 in the GAL binding domain (nicknamed “Bokar” by
our lab) was shown to interact with Wtap in the GAL activation domain. b. Wtap in the
43

activation domain was transformed with empty GAL binding domain to ensure that it did not
auto-activate. c. Mettl3 amino acids 273-580 in the GAL binding domain was transformed with
GAL activation domain to make sure that Mettl3 amino acids 273-580 did not auto-activate.

Motivation to study Wt1 protein interactions
Wtap has been verified to be a binding partner of Wt1 in yeast two hybrid assays (Little,
Hastie, and Davies 2000). We tested the interaction between Wtap and Wt1 as a positive control.
Furthermore, we were interested in discerning the interaction betweenWt1 and Mettl3.
Cloning the WT1 gene
The WT1 gene was ligated using EcoRI and SalI restriction sites, which flanked the WT1
insert. A PCR amplification using specific primers (primer sequence found in Materials section)
contained the restriction sites that flanked the insert. The insert had the same restriction sites that
its associated vector had so there were no compatibility issues. The vector was the GAL4
activation domain, which had the same restriction sites necessary for an efficacious ligation.
Wt1 and Wtap protein-protein interaction
We performed a yeast two hybrid assay to test the interaction between Wt1 in the pADGAL4-2.1 vector and Wtap in the pBD-GAL4 Cam vector. Interestingly, these proteins did not
interact in the assays we performed. We also did a Wtap binding domain and empty Gal-4
activation domain plasmid control, and we did not see an interaction. Furthermore, we did a
control of Wt1 in the Gal-4 activation domain vector and transformed it with empty Gal-4
binding domain control, and we they did not interact. The absence of an interaction is most likely
due to the Wt1 isoform we used to test this interaction.
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Wt1 and Mettl3 273-580 protein-protein interaction
Utilizing the yeast two hybrid assays, we assessed the interaction between Wt1 in the
Gal-4 activation domain vector and the fragmented Mettl3 273-580 protein which was cloned
into the Gal-4 binding domain vector. We did not observe an interaction between these proteins
in our assays. We also verified that these proteins did not auto-activate by transforming them
with empty vectors. Wt1 in the Gal-4 activation domain vector was transformed with empty Gal4 binding domain plasmid, and no interaction was observed in this experiment. Mettl3 273-580
in its binding domain vector was transformed with empty Gal-4 activation domain plasmid, and
this protein did not auto-activate in our assays.
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Discussion
Protein complexes govern many processes that occur within cells. Discerning the proteins
that regulate protein complexes is crucial to understanding the function of these proteins, and the
function of the protein complex in its entirety. The N6-methyladenosine (m6A) modification is
known to be regulated by a protein complex. The role of the m6A modification is still unclear,
but this modification is incredibly significant. It is unlikely that there is one unifying role behind
this modification, but it may play many roles in cellular processes such as effecting
transcriptional fate and regulation, mRNA metabolism, translational efficiency and control,
protein transport, and regulating cellular transformations. m6A is the most prevalent internal
messenger RNA modification detected in eukaryotes and in RNA of nuclear replicating
organisms (Fine-tuning of RNA Functions by Modification and Editing 2005). The m6A
modification is catalyzed by methyltransferases found in all organisms (e.g. Ime4 in yeast and
Mettl3 in humans). These methltransferases are recognized to be in complex with other proteins
that may regulate, enhance, or repress the catalysis of these methyltransferases. Understanding
the exact function of m6A through experiments which directly invoke an alteration in this
modification is perplexing, which is shown by many pleiotropic methlylation inhibitor
experiments. It appears more fathomable to elucidate the function or functions of m6A by
illuminating the protein-protein interactions that are associated in the protein complex that
catalyzes this modification.
Ime4 in yeast catalyzes the methylation of pre-mRNA transcripts. Ime4 was hypothesized
to reside in a protein complex that facilitated its catalysis, which is to transfer reactive methyl
groups bound to sulfur in S-adenosyl methionine (SAM). It has since been verified that Ime4 is
in complex with two proteins known as Mum2 and Slz1. Mum2 is known to be an essential
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protein in the Mum2-Ime4-Slz1 (MIS) complex. Our results show that Mum2 interacted in the
amino acid region 131 through 225 within the N-terminal region of Ime4, which we considered
the leucine rich region. In this thesis, we have hypothesized that Mum2 may scaffold other
proteins to this complex. The leucine region of Ime4 contains alpha helices that may bind the
Mum2 coiled-coil protein.
Mum2 was verified to interact with Ygl036w in two independent experiments, which
were affinity capture and yeast two hybrid assays. With this information, we tested whether
Ygl036w would interact directly with the full length protein (amino acids 1-600) and its
fragments. We observed that Ygl036w interacted with the full length Ime4 protein. We were also
convinced that Ygl036w specifically interacted within the N-terminal region of Ime4, but
experiments to confirm this are still ongoing because we established that the N-terminal
fragment of Ime4 self-activated in yeast two hybrid screens. Also, we observed that Ygl036w
does not interact in the catalytic region of Ime4 (amino acids 231-600) or the leucine rich region
of Ime4. Similar results were shown with the Bur2 protein. The Bur2 protein interacted with the
full length Ime4 protein, but does not interact with the leucine rich or catalytic region of Ime4.
Experiments are still partial in concluding whether Bur2 interacts in the N-terminal of Ime4
because of its difficult screening due to the N-terminal self-activating in yeast two hybrid
experiments. We do not know the importance of these interactions with Ime4. We will be
conducting gene deletion experiments to assess whether these interactions play a role in yeast
cell viability or the sporulation process. We hypothesize that Bur2 may, in some manner, target
Ime4 to RNA transcripts because of its interaction with RNA polymerase. Nothing can be said
about Ygl036w and its interaction with Ime4 because there is virtually nothing known about this
protein.
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The human homolog of Ime4 is termed Mettl3, which is hypothesized to reside in an
enormous protein complex. However, to our knowledge, the proteins that interact in this complex
remain elusive. Mettl3 catalyzes the same function that Ime4 catalyzes, which is to methylate
adenosine residues of mRNA transcripts internally. The mechanism by which this occurs is still
unclear, and the proteins that regulate this modification catalyzed by Mettl3 are still unknown.
Mettl3 amino acids 273-580 in the GAL binding domain was suspected to interact with Wtap in
the GAL activation domain in our yeast two hybrid assays. We will need to perform future pull
down assays to confirm this interaction. Wtap may act in a similar manner to Mum2, which is
hypothesized to scaffold proteins to the Ime4 complex. Or Wtap may act as a splicing factor and
affect the fate of methylated transcripts. Experiments are ongoing to elucidate these hypotheses.
Also, it is necessary to make the connection that Wtap associates with the Wilms’ tumor protein
1 (Wt1), which has an essential role in the normal development of the urogenital system. Mettl3
may play a regulatory role in the function of Wt1 if it is found to interact with either Wt1 or
Wtap.
Importantly, the m6A modification has remained evolutionarily conserved in all
organisms over time. This is significant because natural selection conserved the genes that
function to catalyze this modification. This conservation proves necessary for organisms to
sustain their continued survival overtime. The most studied proteins that catalyze the m6A
modification include Saccharomyces Cerevisiae, Homo sapiens, Arabidopsis thaliana, and
Drosophila melanogaster. These proteins are termed Ime4, Mettl3, Mta, and Dm Ime4
respectively. Deficiency experiments have revealed the importance of these proteins. Induced
experimental deficiency of Mettl3 is detrimental and leads to apoptosis in Homo sapiens (Finetuning of RNA Functions by Modification and Editing 2005). Developmental arrest was observed
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in Arabidopsis thaliana when Mta was inhibited of its activity (Zhong et al. 2008). Defects in
gametogenesis were verified when Ime4 and Dm Ime4 were silenced in Saccharomyces
Cerevisiae and Drosophila melanogaster, respectively(Clancy et al. 2002; Hongay and OrrWeaver 2011). Discovering the exact function or functions of m6A and the proteins that interact
in these complexes that catalyze this modification may prove to be medically relevant.
In Homo sapiens, experiments have revealed that the knockdown of Mettl3 resulted in
apoptosis of Hep2G cells (Dominissini et al. 2012). Cells undergoing transformations, whether it
may be normal cellular transformations or harmful ones, the methylation of adenosine residues in
mRNA transcripts increases. The reason this occurs remains unclear, but it may have to do with
an increased amount of translated proteins that cells need for specific transformations. Silencing
the m6A methyltransferase is also known to considerably affect gene expression and alternative
splicing patterns (Dominissini et al. 2012). Experiments performed by silencing METTL3
resulted in the inactivation of specific isoforms of MDMX, which is a key gene that regulates the
activation of the p53 gene (a tumor suppressor gene). MDMX is a gene that is needed for the
inactivation of the p53 gene (Dominissini et al. 2012). The p53 protein is critical in regulating
the cell cycle and preventing cancer in humans. When this gene is mutated, cells become
immortal and begin to divide sporadically. This leads to metastatic cancers and death as a result
of these cancerous cells affecting regular organ function. On this notion, altering the manner in
which transcripts are methylated may one day serve to be therapeutically beneficial in treating
cancers and other diseases that may be caused by proteins that are not translated by the lack of
m6A modified transcripts. Down-regulating transcripts that are overexpressed in diseases such as
trisomy 21 by inhibiting the m6A modification may prove to be a noteworthy treatment.
Remarkably, a protein called FTO (Fat mass and obesity associated protein) catalyzes oxidative
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demethylation of m6A residues in mRNA transcripts in humans (Jia et al. 2011). FTO has been
revealed to affect energy homeostasis, human obesity, and is associated with Alzheimer’s disease
(Jia et al. 2011). Exactly how the demethylation of these mRNA transcripts is associated with
these factors remains to be clarified. By lowering the amount of m6A residues on transcripts,
translation of proteins, regulation of mRNA metabolism, and transportation of transcripts to and
from the nucleus may be affected in some manner. These reasons may justify targeting m6A or
increasing the catalysis of the proteins that modify transcripts may serve as being medically
beneficial.
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